Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Exercise × 90 days × Clear all

Sponsor

Conditions

Motor Activity 20 Breast Neoplasms 11 Neoplasms 6 Obesity 3 Lymphoma, Follicular 3 Lymphedema 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Sarcopenia 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Brain Neoplasms 2 Skin Neoplasms 1 Recurrence 1 Psychological Well-Being 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Myeloproliferative Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Essential Hypertension 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡